SIMC yields 2000000.00% · MRK yields 2.81%● Live data
📍 SIMC pulled ahead of the other in Year 1
Combined, SIMC + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SIMC + MRK for your $10,000?
Simclar, Inc., together with its subsidiaries, operates as a contract manufacturer of electronic and electro-mechanical products in the United States and Mexico. Its custom-designed products include complex printed circuit boards (PCBs), finished products, subassemblies, molded and nonmolded cable assemblies, wire harnesses, injection molded, and electronic assembly products. The PCBs produced by the company comprise pin-through-hole assemblies, low and medium volume surface mount technology assemblies, and mixed technology PCBs, including multilayer PCBs; and cable and harness assemblies consist of multiconductor, ribbon, coaxial cable, and discrete wire harness assemblies. The company also provides contract manufacturing services, which involves the manufacture of complete finished assemblies with all sheet metal, power supplies, fans, and PCBs, as well as complete sub-assemblies for integration into original equipment manufactures (OEMs) finished products, such as speaker and lock-key assemblies, and diode assemblies. In addition, Simclar offers reworking and refurbishing services, which comprise redesign, rework, refurbish, and repair of materials and subassemblies; sheet metal fabrication services; and backplane interconnect solutions. The company's products are manufactured to customer specifications and designed for OEMs in the data processing, telecommunications, instrumentation, and food preparation equipment industries. The company was formerly known as Techdyne, Inc. and changed its name to Simclar, Inc. in September 2003. The company was founded in 1976 and is based in Hialeah, Florida. Simclar, Inc. operates as a subsidiary of Simclar Group Limited.
Full SIMC Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.